Patient Guide: Study of Pembrolizumab (MK-3475) Subcutaneous (SC) Versus Pembrolizumab Intravenous (IV) Administered With Platinum Doublet Chemotherapy in Participants With Metastatic Squamous or Nonsquamous Non-Small Cell Lung Cancer (NSCLC) (MK-3475-A86)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 126 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04956692
Status: ACTIVE_NOT_RECRUITING
Condition: Non-Small Cell Lung Cancer
Phase: PHASE3

Find a Study Location Near You

This study is available at 126 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Jonesboro, Arkansas
  • Fullerton, California
  • Los Alamitos, California
  • • And 123 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily